It is likely that a reduction in insulin levels contributes to the anti-cancer effects of insulin, especially on cancer types that have been linked with obesity, metabolic syndrome, and hyperinsulinemia, including gastrointestinal and breast cancers [124]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.